中国的乳癌治疗药市场
市场调查报告书
商品编码
81745

中国的乳癌治疗药市场

Breast Cancer Treatment Drug Markets in China

出版日期: | 出版商: Asia Market Information & Development Co. | 英文 256 Pages | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

中国的乳癌治疗药需求在过去十年急速扩大。一般预测今后五年,生产及需求都将顺利成长。

本报告提供中国的经济趋势,投资环境,产业的发展,需求及供给,产业结构,市场流通管道及主要企业等相关详细调查,加上过去的实际成果和长期预测等,为您概述为以下内容。

第1章 简介

  • 本调查报告的范围和方法论
  • 摘要整理

第2章 商务环境

  • 经济展望
    • 主要的经济指标
    • 工业生产量
    • 人口及人力资源
    • 来自海外的投资
    • 海外贸易
  • 金融及税金的法规
    • 银行制度及法规
    • 外汇
    • 税金,关税及海关

第3章 乳癌治疗药产业评估

  • 产业结构
  • 市场规模
  • 推动市场成长要素
  • 销售量
  • 主要製造商的设备据点
  • 主要製造厂商的销售量及市场占有率
  • 劳动成本
  • 有潜在性的参与企业
  • 主要的经销商
  • 主要的海外投资
  • 技术开发

第4章 乳癌治疗药的生产及需求

  • 概要
  • 销售量
    • 化疗剂
    • Paclitaxel
    • Fluoropyrimidines
    • 蒽环类抗生素
    • 标靶治疗药
    • 治疗抗体
    • 小分子药
    • Aromatase抑制剂(标靶治疗药)
    • 内分泌腺治疗药
    • 抗雌激素
    • 孕甾酮
    • Aromatase抑制剂(内分泌腺治疗药)
    • LH-RH
  • 进口
    • 化疗剂
    • Paclitaxel
    • Fluoropyrimidines
    • 蒽环类抗生素
    • 标靶治疗药
    • 治疗抗体
    • 小分子药
    • Aromatase抑制剂(标靶治疗药)
    • 内分泌腺治疗药
    • 抗雌激素
    • 孕甾酮
    • Aromatase抑制剂(内分泌腺治疗药)
    • LH-RH
  • 价格趋势

第5章 乳癌治疗药市场展望

  • 乳癌治疗药市场展望
  • 政府的法规
  • 健康保险产业概要
  • 消费者支出趋势
  • 人口动态
  • 医疗保健产业趋势
  • 医院及病床
  • 医生及出诊

第6章 市场进入流通管道

  • 打入中国市场概要
    • 中国流通系统
    • 流通管道
    • 运输及运输基础设施
    • 通讯
  • 打入中国市场
    • 对中国出口
    • 间接出口
    • 直接出口
    • 专利及联盟製造
    • 中国内的组装
    • 联盟製造
    • 贸易许可
    • 投资
    • 资本联盟
    • 合併企业
    • 完全外资企业

第7章 乳癌治疗药製造商目录

  • 製造商简介及目录
  • 主要的终端用户

图表清单

Product Code: 822

China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS

  • Breast Cancer Treatment Drug Industry Structure
  • Market Size
  • Market Growth Driver
  • Breast Cancer Treatment Drug Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND

  • Overview
  • Breast Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug
  • Paclitaxel
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Progesterone
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Breast Cancer Treatment Drugs Import
  • Chemotherapeutic Drug
  • Paclitaxel
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Progesterone
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Pricing Trend

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Breast Cancer Treatment Drug Markets Outlook Overview Concrete Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS

  • China Market Entry Overview
  • China's Distribution System
  • Breast Cancer Treatment Drug Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY

  • Breast Cancer Treatment Drug Producer Profiles and Directory

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS

  • Breast Cancer Treatment Drug Sales Volume
  • Major Producer Facility Locations
  • Major Breast Cancer Treatment Drug Producer Sales Volume and Market Share
  • Major Foreign Investments

IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND

  • Total Breast Cancer Treatment Drugs Sales Volume
  • Breast Cancer Treatment Drug Major Producer and Their Market Share
  • Chemotherapeutic Drug Major Producer and Their Market Share
  • Paclitaxel Major Producer and Their Market Share
  • Fluoropyrimidines Major Producer and Their Market Share
  • Anthracycline Antibiotics Major Producer and Their Market Share
  • Targeted Therapy Drug Major Producer and Their Market Share
  • Therapertic Antibody Major Producer and Their Market Share
  • Small Molecules Drug Major Producer and Their Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
  • Endocrine Therapy Drug Major Producer and Their Market Share
  • Anti-estrogens Major Producer and Their Market Share
  • Progesterone Major Producer and Their Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
  • LH-RH Major Producer and Their Market Share
  • Breast Cancer Treatment Drugs Import

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Breast Cancer Treatment Drug Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. ANTIFREEZE & THAWING AGENT INDUSTRY ASSESSMENTS

  • Chemotherapeutic Drug Sales Volume by Drugs Classification
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Endocrine Therapy Drug Sales Volume by Drugs Classification
  • Breast Cancer Treatment Drug Sales Volume

IV. ANTIFREEZE & THAWING AGENT PRODUCTION AND DEMAND

  • Breast Cancer Treatment Drug Sales Volume
  • Chemotherapeutic Drug Sales Volume and Market Share
  • Chemotherapeutic Drug Sales Volume by Drugs Classification
  • Paclitaxel Sales Volume and Market Share
  • Fluoropyrimidines Sales Volume and Market Share
  • Anthracycline Antibiotics Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Therapertic Antibody Sales Volume and Market Share
  • Small Molecules Drug Sales Volume and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share
  • Endocrine Therapy Drug Sales Volume and Market Share
  • Endocrine Therapy Sales Volume by Drugs Classification
  • Anti-estrogens Sales Volume and Market Share
  • Progesterone Sales Volume and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
  • LH-RH Sales Volume and Market Share
  • Breast Cancer Treatment Drugs Import
  • Chemotherapeutic Drug Import and Market Share
  • Chemotherapeutic Drug Import by Drugs Classification
  • Paclitaxel Import and Market Share
  • Fluoropyrimidines Import and Market Share
  • Anthracycline Antibiotics Import and Market Share
  • Targeted Therapy Drug Import and Market Share
  • Targeted Therapy Drug Import by Drugs Classification
  • Therapertic Antibody Import and Market Share
  • Small Molecules Drug Import and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
  • Endocrine Therapy Drug Import and Market Share
  • Endocrine Therapy Drug Import by Drugs Classification
  • Anti-estrogens Import and Market Share
  • Progesterone Import and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
  • LH-RH Import and Market Share

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Breast Cancer Treatment Drugs Demand by Market

VI. MARKETING STRATEGIES

  • China's Distribution Channel